Terms: = Liver cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Treatment
57 results:
1. Integrating Navigation-Assisted Ablation in the Locoregional treatment of Hepatocellular Carcinoma.
Iwai Y; Agala CB; Gerber DA
JAMA Netw Open; 2024 Feb; 7(2):e240694. PubMed ID: 38421644
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation a radiomics nomogram for predicting thymidylate synthase status in hepatocellular carcinoma based on Gd-DTPA contrast enhanced MRI.
Ding Z; Wu Y; Fang G; Lin Z; Lin K; Fu J; Huang Q; Tang Y; You W; Liu J; Zeng Y
BMC Cancer; 2023 Oct; 23(1):991. PubMed ID: 37848807
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy of CalliSpheres® microspheres versus conventional transarterial chemoembolization in the treatment of refractory colorectal cancer liver metastasis.
Li H; Zhang X; Zhao W; Cai F; Qin J; Tian J
BMC Cancer; 2023 Oct; 23(1):970. PubMed ID: 37828491
[TBL] [Abstract] [Full Text] [Related]
4. Vessels encapsulating tumor clusters: a novel efficacy predictor of hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma.
Lin W; Lu L; Zheng R; Yuan S; Li S; Ling Y; Wei W; Guo R
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17231-17239. PubMed ID: 37801135
[TBL] [Abstract] [Full Text] [Related]
5. Transarterial chemoembolization plus lenvatinib with or without a PD-1 inhibitor for advanced and metastatic intrahepatic cholangiocarcinoma: a retrospective real-world study.
Ning Z; Xie L; Yan X; Hua Y; Shi W; Lin J; Xu L; Meng Z
Br J Radiol; 2023 Oct; 96(1150):20230079. PubMed ID: 37660471
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy of a Second Course of Radiation for Patients With Metachronous Hepatocellular Carcinoma.
Gharzai LA; Wang C; Tang M; Jackson WC; Maurino C; Cousins MM; Mendiratta-Lala M; Parikh ND; Mayo CS; Haken RKT; Owen D; Cuneo KC; Schipper MJ; Lawrence TS
Pract Radiat Oncol; 2023; 13(6):e504-e514. PubMed ID: 37295727
[TBL] [Abstract] [Full Text] [Related]
7. CAGE-B and SAGE-B models better predict the hepatitis B virus-related hepatocellular carcinoma after 5-year entecavir treatment than PAGE-B.
Chon HY; Lee HA; Park SY; Seo YS; Kim SG; Lee CH; Lee TH; Ahn SH; Wong VW; Yip TC; Liang LY; Kim IH; Wong GL; Kim SU
J Dig Dis; 2023 Feb; 24(2):113-121. PubMed ID: 37057685
[TBL] [Abstract] [Full Text] [Related]
8. Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database.
Rijken A; Bakkers C; Klümpen HJ; van der Geest LG; de Vos-Geelen J; van Erning FN; de Hingh IHJT
Eur J Surg Oncol; 2023 Aug; 49(8):1436-1443. PubMed ID: 36898900
[TBL] [Abstract] [Full Text] [Related]
9. Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea-Japan collaborative study with 9200 patients.
Kang WH; Hwang S; Kaibori M; Kim JM; Kim KS; Kobayashi T; Kayashima H; Koh YS; Kubota K; Mori A; Takeda Y; Yun SS; Matsui K; Toriguchi K; Nagano H; Yoon MH; Soejima Y; Ariizumi S; Kim BS; Park Y; Yu HC; Kim BW; Lee JB; Park SJ; Jang JY; Yamaue H; Nakamura M; Yamamoto M; Endo I; ;
J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):993-1005. PubMed ID: 36808234
[TBL] [Abstract] [Full Text] [Related]
10. Natural history of decompensated cirrhosis with serum hepatitis B DNA < 2000 IU/mL: a retrospective study.
Huang X; Yan M; Deng Z; Yao L; Han D; Sun L
BMC Gastroenterol; 2022 Nov; 22(1):452. PubMed ID: 36352372
[TBL] [Abstract] [Full Text] [Related]
11. Can patients with gallbladder adenocarcinoma and liver metastases obtain survival benefit from surgery? A population-based study.
Gao T; Tang H; Zhou B; Bai D; Jin S; Zhang C; Jiang G
Updates Surg; 2022 Aug; 74(4):1353-1366. PubMed ID: 35661322
[TBL] [Abstract] [Full Text] [Related]
12. From open Ivor Lewis esophagectomy to a hybrid robotic-assisted thoracoscopic approach: a single-center experience over two decades.
Angehrn FV; Neuschütz KJ; Fourie L; Wilhelm A; Däster S; Ackermann C; von Flüe M; Steinemann DC; Bolli M
Langenbecks Arch Surg; 2022 Jun; 407(4):1421-1430. PubMed ID: 35332369
[TBL] [Abstract] [Full Text] [Related]
13. Can liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis.
Vestito A; Dajti E; Cortellini F; Montagnani M; Bazzoli F; Zagari RM
Ultraschall Med; 2023 Jun; 44(3):e139-e147. PubMed ID: 34758491
[TBL] [Abstract] [Full Text] [Related]
14. Observational study of the relative efficacy of insulin-glucose treatment for hyperkalaemia in patients with liver cirrhosis.
Lim AKH; Crnobrnja L; Metlapalli M; Jiang C; Wang RSH; Pham JH; Abasszade JH
BMJ Open; 2021 Oct; 11(10):e051201. PubMed ID: 34686554
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic nomogram predicting survival of patients with unresectable hepatocellular carcinoma after hepatic arterial infusion chemotherapy.
Mei J; Lin WP; Shi F; Wei W; Liang JB; Shi M; Zheng L; Li SH; Guo RP
Eur J Radiol; 2021 Sep; 142():109890. PubMed ID: 34375811
[TBL] [Abstract] [Full Text] [Related]
16. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial.
Vogel A; Qin S; Kudo M; Su Y; Hudgens S; Yamashita T; Yoon JH; Fartoux L; Simon K; López C; Sung M; Mody K; Ohtsuka T; Tamai T; Bennett L; Meier G; Breder V
Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):649-658. PubMed ID: 34087115
[TBL] [Abstract] [Full Text] [Related]
17. Comparative Effectiveness of Machine Learning Approaches for Predicting Gastrointestinal Bleeds in Patients Receiving Antithrombotic treatment.
Herrin J; Abraham NS; Yao X; Noseworthy PA; Inselman J; Shah ND; Ngufor C
JAMA Netw Open; 2021 May; 4(5):e2110703. PubMed ID: 34019087
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy of the association liver partition and portal vein ligation for staged hepatectomy for the treatment of solitary huge hepatocellular carcinoma: a retrospective single-center study.
Deng Z; Jin Z; Qin Y; Wei M; Wang J; Lu T; Zhang L; Zeng J; Bao L; Guo Y; Peng M; Xu B; Wen Z
World J Surg Oncol; 2021 Mar; 19(1):95. PubMed ID: 33785022
[TBL] [Abstract] [Full Text] [Related]
19. Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first-line treatment of systemic light chain amyloidosis in the UK.
Sharpley FA; Manwani R; Petrie A; Mahmood S; Sachchithanantham S; Lachmann HJ; Martinez De Azcona Naharro A; Gillmore JD; Whelan CJ; Fontana M; Cohen O; Hawkins PN; Wechalekar AD
Eur J Haematol; 2021 Apr; 106(4):537-545. PubMed ID: 33460466
[TBL] [Abstract] [Full Text] [Related]
20. Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced Hypersplenism.
Jácome AA; Ohinata A; Mahvash A; Overman MJ; Kee B; Fogelman D; Morris VK; Johnson B; Rothschild ND; Wolff RA; Eng C
Clin Colorectal Cancer; 2020 Dec; 19(4):e189-e199. PubMed ID: 32680816
[TBL] [Abstract] [Full Text] [Related]
[Next]
